Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Adesso BioProducts AB

Closing information (x1000 SEK)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 1,727,729 More Arrow 2,662,900 More Arrow 2,727,943
Financial expenses 7,064 More Arrow 16,608 Less Arrow 11,016
Earnings before taxes 185,474 More Arrow 206,127 Less Arrow 167,702
EBITDA 183,893 More Arrow 217,674 Less Arrow 179,848
Total assets 876,251 Less Arrow 827,708 More Arrow 902,489
Current assets 858,803 Less Arrow 810,852 More Arrow 884,714
Current liabilities 171,198 More Arrow 243,654 More Arrow 324,567
Equity capital 625,053 Less Arrow 504,054 Less Arrow 443,322
- share capital 100 Equal arrow 100 Equal arrow 100
Employees (average) 22 More Arrow 24 Less Arrow 21

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 71.3% Less Arrow 60.9% Less Arrow 49.1%
Turnover per employee 78,533 More Arrow 110,954 More Arrow 129,902
Profit as a percentage of turnover 10.7% Less Arrow 7.7% Less Arrow 6.1%
Return on assets (ROA) 22.0% More Arrow 26.9% Less Arrow 19.8%
Current ratio 501.6% Less Arrow 332.8% Less Arrow 272.6%
Return on equity (ROE) 29.7% More Arrow 40.9% Less Arrow 37.8%
Change turnover -935,171 More Arrow -65,043 More Arrow 225,998
Change turnover % -35% More Arrow -2% More Arrow 9%
Chg. No. of employees -2 More Arrow 3 Less Arrow 0
Chg. No. of employees % -8% More Arrow 14% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.